ReviewJournal of cancer survivorship : research and practice2026
Infertility, the outcomes of assisted reproductive technologies use in childhood cancer survivors: a scoping review.
Review in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeChildhood cancer survivors (CCS) are at increased risk of treatment-related infertility and may require assisted reproductive technologies (ART) to achieve parenthood. This scoping review aimed to synthesise the existing scientific evidence on the use of ART among CCS, focusing on fertility outcomes and associated maternal, perinatal, and child health indicators.
methodsAdapted from Joanna Briggs Institute (JBI) and PRISMA-ScR guidelines, MEDLINE (OVID), CINAHL, and Embase were searched (conducted from the inception of each database up to February 2025) for studies of CCS diagnosed before age 18, surviving ≥ 5 years, and reporting ART-related fertility, obstetric, or perinatal outcomes. Screening and extraction were conducted independently via Covidence.
resultsFrom 4,785 records, 10 studies met the inclusion criteria. Five studies reported higher infertility rates among female CCS (4.5-34%) compared with non-cancer controls. ART success rates were generally comparable to siblings, though pelvic or cranial radiotherapy reduced live birth rates by 17-32%. Three studies demonstrated the feasibility of ovarian tissue cryopreservation (OTC), particularly for prepubertal girls. Male CCS were more likely to require intracytoplasmic sperm injection (ICSI) and had lower ART success than non-cancer siblings. Neonatal studies found increased multiple gestations, preterm births, and low birth weight among ART-conceived offspring, but no rise in congenital anomalies or childhood cancer.
conclusionART enables parenthood for childhood cancer survivors, though prior gonadotoxic therapies can impair success and increase perinatal risks, highlighting the need for long-term survivorship research. IMPLICATIONS FOR CANCER SURVIVORS: ART provides viable fertility options, but early counseling and integrated reproductive care are essential to optimise outcomes and ensure equitable access for all cancer survivors.
Indexed as
Identifiers
41697508What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.